Frequently Asked Questions
The market is segmented based on , By Type (Output Neural Prosthetics and Input Neural Prosthetics), Technique (Deep Brain Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation and Sacral Nerve Stimulation), Application (Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders), End User (Hospitals and Clinics) – Industry Trends and Forecast to 2031.
.
The Global Neuroprosthetics Market size was valued at USD 24.03 USD Billion in 2023.
The Global Neuroprosthetics Market is projected to grow at a CAGR of 14.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Boston Scientific Corporation (U.S.), Zimmer Biomet (U.S.), Cochlear Ltd. (Australia), Medtronic (U.S.), NDI Medical, LLC (U.S.), NeuroPace, Inc. (U.S.), NEVRO CORP (U.S.), Abbott (U.S.), Sonova (Switzerland), CorTec GmbH (Germany), Neuro Device Group S.A. (Poland), LivaNova PLC (U.K.), and MED-EL Medical Electronics (Austria).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
